Associations and dissociations between serum bone Gla protein and alkaline phosphatase in skeletal metabolism.
Serum bone Gla protein (BGP) and alkaline phosphatase (AP) activity were compared for the assessment of skeletal status in 11 normal pregnant women, 12 normal women on days 3 and 13 of the menstrual cycle, five postmenopausal women before and after 1 month of treatment with ethinyl estradiol (20 micrograms/day), five patients with cancer and hypercalcemia during treatment with calcitonin, and one patient with Paget disease during treatment with Plicamycin. BGP and AP correlated with each other only in the pregnant women. In all other circumstances, there was no correlation between these two serum osteoblast products. Furthermore, there were conditions in which the two measurements became discordant. These studies demonstrate that BGP and AP commonly are dissociated when used as measurements of skeletal status. Although both are osteoblast products, BGP and AP probably reflect different aspects of osteoblast differentiation and function.
Parthemore
J G
JG
Department of Medicine, University of California, San Diego.
Burton
D W
DW
Deftos
L J
LJ
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood*; D002116:Calcitonin / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000150:complications / Q000188:drug therapy; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000150:complications / Q000188:drug therapy; D008175:Lung Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000150:complications / Q000188:drug therapy; D015675:Osteocalcin / Q000097:blood*; D017698:Postmenopause / Q000097:blood; D011247:Pregnancy / Q000097:blood
D015675:Osteocalcin; D004997:Ethinyl Estradiol; C028815:salmon calcitonin; D002116:Calcitonin; D000469:Alkaline Phosphatase